About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 40119 record(s)
Req # A-2023-001103
The proposal listed in the response to Order Paper Question No. 1754: "Canada has put forward a proposal to Conference of the Parties (COP) to consider exploring tobacco control measures that extend beyond the provisions of the World Health…Organization: Health Canada
April 2024
Req # A-2023-001174
The approved labelling for the products BD ONCLARITY HPV ASSAY and BD ONCLARITY HPV ASSAY REAGENT PACK authorized under Licence No. 99811.Organization: Health Canada
April 2024
Req # A-2023-001209
Newest Abbreviated New Drug Submission (ANDS) for liraglutide, the ANDS cover letter of the company who submitted the Second Liraglutide ANDS.Organization: Health Canada
April 2024
Req # A-2023-001299
The most recent Certified Product Information Document (CPID) submitted for the Estradiol Abbreviated New Drug Submission (ANDS).Organization: Health Canada
April 2024
Req # A-2023-001436
Application form for Artron's COVID-19 Antigen Test - IO 327866.Organization: Health Canada
April 2024
Req # A-2023-001565
Studies suggesting that transgender people face substantial barriers to abortion services.Organization: Health Canada
April 2024
Req # A-2023-001593
The statements made by federal Health Minister Mark Holland to the media on March 20, 2024. The email or letter correspondence referenced by Mr. Holland, which was stated to have been sent to the provincial and territorial health ministries in…Organization: Health Canada
April 2024
Req # A-2020-001030
Adverse Drug Reactions (ADRs). Report numbers: 000721620, 000721621, 000721623, 000721654, 000721705, 000721791, 000721858, 000721859, 000722031, 000722048, 000722071, 000722086, 000722112, 000722119, 000722122, 000722123, 000722145, 000722159,…Organization: Health Canada
April 2024
Req # A-2020-001430
Adverse Drug Reactions (ADRs). Report numbers: E2B_02959763, E2B_02959832, E2B_02959837, E2B_02960718, E2B_02961718, E2B_02961975, E2B_02962182, E2B_02962222, E2B_02962228, E2B_02962240, E2B_02962267, E2B_02962383, E2B_02962725, E2B_02962736,…Organization: Health Canada
April 2024
Req # A-2020-001535
Adverse Drug Reactions (ADRs). Report numbers: E2B_03106484, E2B_03107034, E2B_03107273, E2B_03107558, E2B_03107824, E2B_03108501, E2B_03109625, E2B_03110378, E2B_03110399, E2B_03110511, E2B_03110611, E2B_03110675, E2B_03111060, E2B_03111289,…Organization: Health Canada
April 2024